Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 23/07/13

Trade details

Type: Insider sale
Amount: $1,380,355.2
Shares · price: 55,104 sh · $25.05 a share
Held after: 36,695 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 23/07/12
Filed: 23/07/13
Days to filing: 1 days

Sold 60.0% of holdings

Share of holding sold: 60.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/06/12~23/08/11

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$485.1K
31,747 sh
$485.1K
Filed 24/08/20
Traded 24/08/19
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$193.6K
11,427 sh
$193.6K
Filed 24/05/03
Traded 24/05/02
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$317.1K
17,714 sh
$317.1K
Filed 24/03/27
Traded 24/03/27